Table of contents
- Medical Disclaimer
- Overview
- Two programs, two agencies
- Where the line is drawn: the definition of “cannabis”
- What makes something “hemp”
- How Alabama now regulates consumable hemp: House Bill 445
- Why the confusion exists in the first place
- The core differences, side by side
- Why the distinction matters for patients
- An evolving picture, including at the federal level
- Key takeaways
- Alabama Residents Also Ask
- Article References
- Additional Reading
Medical Disclaimer
Educational resource. Last reviewed: September 2026. This article explains Alabama’s regulatory framework for general education. It is not legal advice. Program rules can change; verify current requirements with the Alabama Medical Cannabis Commission.
By Homestead Health – Alabama’s Leader in Pharmaceutical-Grade Medical Cannabis Processing
Overview
For years, Alabamians could walk into a gas station or vape shop and buy “CBD” or “delta-8” products, while the state’s actual medical cannabis program did not yet exist. That history created deep and lasting confusion: if cannabis-derived products were already on store shelves, many people reasonably wondered, what is the medical program even for? The answer is that Alabama now has two entirely separate legal regimes for cannabis-derived products – regulated by two different state agencies, under two different laws, with different products, different access rules, and different protections. Understanding the distinction is essential for anyone trying to make sense of their options.
This article explains the difference between the state’s medical cannabis program and the hemp and CBD products sold in retail stores. It is written for patients, caregivers, and curious readers, and it reflects a landscape that changed substantially in 2025 and 2026. Because the hemp side of this picture is evolving and contested, this piece describes the current framework while flagging its uncertainty; it is not legal advice.
Two programs, two agencies
The single most important thing to understand is that “medical cannabis” and “hemp/CBD products” are governed by different laws and different regulators in Alabama:
- Medical cannabis is regulated by the Alabama Medical Cannabis Commission (AMCC) under the Darren Wesley “Ato” Hall Compassion Act. This is the physician-certified, card-based program with licensed dispensaries.
- Consumable hemp products (including CBD and hemp-derived THC items) are regulated by the Alabama Alcoholic Beverage Control (ABC) Board under a 2025 law, House Bill 445 [1][2].
These are not two names for the same thing. They are parallel systems, and a product’s legality, potency, testing, and point of sale depend entirely on which system it belongs to. The confusion most people experience comes from treating them as one blurry category when they are, in law, distinct.
Where the line is drawn: the definition of “cannabis”
The legal separation begins with a definition. Under the Compassion Act, “cannabis” means all parts of the plant of the genus Cannabis, including seeds, extractions, and every compound or derivative – but the definition expressly excludes industrial hemp or hemp regulated under Alabama’s separate hemp article [3]. In other words, the medical cannabis law defines itself in a way that carves hemp out. Hemp is legally not the “cannabis” the medical program governs.
This carve-out is the root of the whole distinction. The same plant genus produces both, but the law sorts products into “hemp” or “cannabis” based primarily on THC content, and then routes each into a different regulatory system.
What makes something “hemp”
The dividing line is a threshold of delta-9-THC. Under the federal 2018 Farm Bill definition that Alabama follows, “hemp” is cannabis containing no more than 0.3% delta-9-THC on a dry-weight basis [4]. Anything above that threshold is, federally, “marijuana”; anything at or below it is “hemp.” This is a legal threshold, not a botanical one – the plants are the same species, distinguished by their THC concentration and, consequently, by which body of law applies to them.
Because hemp was federally legalized in 2018, a large market of hemp-derived consumer products emerged nationwide – CBD oils, gummies, and later intoxicating hemp-derived cannabinoids such as delta-8-THC, marketed under the “hemp” banner. In Alabama, these products filled shelves well before the medical program opened. But Alabama has now brought that market under tight state control.
How Alabama now regulates consumable hemp: House Bill 445
In 2025, Alabama enacted House Bill 445, which dramatically overhauled how the state treats consumable hemp products. The law rolled out in two phases [5][2]:
- July 1, 2025: All smokable and inhalable hemp products – including hemp flower, pre-rolls, and delta-8 vapes and cartridges – became prohibited, with violations treated as a serious felony offense [5][2].
- January 1, 2026: A full regulatory framework took effect, placing consumable hemp products under the ABC Board. This framework requires licensing of retailers, mandatory lab testing, labeling, age-21+ sales, and an excise tax, and it prohibits online sales and direct-to-consumer shipments into the state [1][5].
Under this framework, consumable hemp ingestibles are capped at defined potency limits – reported as 10 mg of total THC per serving and 40 mg per package – with total THC calculated after decarboxylation using the standard formula that adds delta-9-THC to THCA adjusted by a conversion factor [5][6]. Critically, the law also targets synthesized cannabinoids: it prohibits psychoactive cannabinoids created by chemical synthesis or conversion from another cannabinoid [2][7]. Because most commercial delta-8 is produced by converting CBD in a lab, this provision has functionally removed much of the delta-8 market from lawful Alabama retail [2].
It bears repeating that this hemp framework is new, actively enforced, and the subject of ongoing constitutional litigation by hemp businesses [8]. The details described here reflect the situation as of this article’s review date and should be re-verified, because few areas of Alabama law are moving faster.
Why the confusion exists in the first place
It helps to understand how Alabamians ended up so confused about this. The timeline created it. The federal 2018 Farm Bill legalized hemp nationwide, and a wave of hemp-derived products – CBD first, then intoxicating cannabinoids like delta-8 – appeared in Alabama gas stations and vape shops. For several years, those products were the only cannabis-derived items a person could readily buy in the state, because Alabama’s medical cannabis program, though authorized in 2021, was tied up in delays and litigation and did not begin sales until 2026.
So for a stretch of time, the public’s entire experience of “cannabis products” in Alabama was the hemp channel – unregulated by any dedicated state framework and widely available without a card. When the medical program finally opened, it arrived into a market where many people already associated cannabis products with casual retail purchase. That history is precisely why the two systems get conflated, and why an article like this one is necessary: the order in which the two markets appeared trained people to think of cannabis products as something you simply buy, rather than something that, in the medical program, requires a physician and a card. HB 445 then reshaped the hemp side just as the medical side was launching, changing both halves of the picture at nearly the same moment.
The core differences, side by side
With both systems in view, the practical differences become clear:
Regulator. Medical cannabis is overseen by the AMCC; consumable hemp by the ABC Board [1].
Access. Medical cannabis requires a qualifying condition, physician certification, and a medical cannabis card. Consumable hemp requires only that a purchaser be 21 or older and buy from a licensed retailer – no card, no physician, no qualifying condition [1][5].
Potency. Medical cannabis products can contain substantially higher THC, dosed by a physician up to the program’s daily limits. Consumable hemp is defined by the 0.3% delta-9 threshold and, for ingestibles, capped at the low per-serving and per-package totals described above [5].
Products and forms. Medical cannabis comes in the specific forms the Compassion Act approves (tablets, tinctures, gel cubes, topicals, patches, and more). Smokable and inhalable hemp is now prohibited in Alabama, and most synthesized-cannabinoid hemp products are effectively off the market [2][5].
Testing and tracking. Medical cannabis moves through a seed-to-sale tracking system with independent, accredited laboratory testing and a certificate of analysis for every batch. Consumable hemp is separately subject to the ABC Board’s testing and labeling rules [5].
Legal protections. Registered medical cannabis patients receive defined protections under the Compassion Act tied to their card and compliance. Buying a hemp product at retail confers no such medical-program status.
Why the distinction matters for patients
For a patient weighing their options, several practical implications follow. First, a store-bought CBD or hemp product is not a substitute for the medical program, nor does buying one make a person a registered patient; the two systems are separate, and only the medical program provides its particular protections and physician oversight. Second, the medical program permits higher-THC products under clinical supervision, whereas consumable hemp is capped at low THC levels by design. Third, the medical program is built around independent testing and traceability tied to each batch – assurances a patient can verify – whereas the reliability of a retail hemp product depends on that separate regulatory channel and its own labeling and testing rules.
None of this is a judgment that one is “better.” It is a statement of what each is and is not. A person seeking a low-THC, over-the-counter product may find the hemp channel relevant; a person with a qualifying condition seeking physician-guided, higher-potency, tested medical cannabis is looking at the AMCC program. Confusing the two – assuming a gas-station product is equivalent to the medical program, or vice versa – leads to poor decisions.
An evolving picture, including at the federal level
Both systems continue to change. Alabama’s hemp framework is new and litigated, and enforcement is still settling. At the federal level, a change to the definition of hemp is scheduled to take effect later in 2026, which would tighten the total-THC standard for hemp products nationwide [2]. Because these rules are in motion, this article is a snapshot rather than a permanent reference. Anyone making decisions based on the current legal status of a specific hemp or CBD product should verify the latest rules with the ABC Board and, for the medical program, with the AMCC – and, for individual legal questions, consult a qualified attorney.
Key takeaways
- Alabama has two separate systems: medical cannabis (AMCC, under the Compassion Act) and consumable hemp (ABC Board, under HB 445) [1][3].
- The Compassion Act’s definition of “cannabis” expressly excludes hemp, which is defined by the 0.3% delta-9-THC threshold [3][4].
- HB 445 (2025–2026) banned smokable/inhalable hemp, capped consumable-hemp potency, restricted synthesized cannabinoids like most delta-8, and moved hemp retail under the ABC Board [2][5].
- Medical cannabis requires a card, a physician, and a qualifying condition, permits higher THC, and is tracked and independently tested; consumable hemp requires only 21+ status and a licensed retailer [1][5].
- The hemp framework is new, enforced, and litigated, and federal hemp rules are also changing – verify current status before relying on it [2][8].
Medical and editorial note: This content is intended to be reviewed by a qualified professional and legal counsel prior to publication, and re-verified frequently because Alabama’s hemp framework (HB 445) is new, enforced, and litigated, and federal hemp rules are changing in late 2026. Homestead Health is a licensed processor in the Alabama Medical Cannabis program; this material is provided for patient and caregiver education and makes no representation regarding the safety or efficacy of any product for any individual, and no legal advice regarding hemp products.
Alabama Residents Also Ask
No. CBD and other hemp products are regulated as consumable hemp under the ABC Board (HB 445), a separate system from the AMCC medical cannabis program. They differ in access, potency, products, and oversight [1][3].
It is a legal threshold: cannabis with no more than 0.3% delta-9-THC on a dry-weight basis is “hemp”; above that, it is treated as marijuana. The plants are the same species, distinguished by THC content [4].
Its status is now highly restricted. HB 445 banned smokable/inhalable hemp and prohibits synthesized cannabinoids; because most delta-8 is made by converting CBD, much of it has effectively left lawful Alabama retail. This area is litigated – verify current status [2][7].
The medical program offers physician oversight, higher-potency options dosed clinically, seed-to-sale tracking, and independent batch testing, plus the Compassion Act’s protections – none of which come with a retail hemp purchase [1].
Yes. If the patient is a minor or has a court-appointed legal guardian, the parent or legal guardian must consent to treatment with medical cannabis [1].
No. The hemp framework is new, actively enforced, and subject to ongoing litigation, and federal hemp rules are changing in late 2026. Treat any specific status as provisional and verify it [2][8].
Article References
Citations Used For This Article
- WAFF 48 News. “New consumable hemp regulations take effect in Alabama.” January 1, 2026. https://www.waff.com/2026/01/01/new-consumable-hemp-regulations-take-effect-alabama/
- Cannabis Regulations. “Is Delta-8 THC Legal in Alabama? 2026 Status After HB 445.” 2026. https://www.cannabisregulations.ai/state-legality/alabama-delta-8
- Darren Wesley “Ato” Hall Compassion Act, §20-2A-3(3), Code of Ala. 1975 (definition of “cannabis”; exclusion of industrial hemp/hemp regulated under Article 11 of Chapter 8 of Title 2). Alabama Medical Cannabis Commission.
- Federal Agriculture Improvement Act of 2018 (2018 Farm Bill) – definition of “hemp” (≤0.3% delta-9-THC by dry weight), as followed in Alabama. https://www.congress.gov/bill/115th-congress/house-bill/2
- Cannabis Regulations. “Is THCA Legal in Alabama? 2026 Status After HB 445” (ABC Board framework; potency caps; total-THC calculation; excise tax; retail and shipping rules). 2026. https://www.cannabisregulations.ai/state-legality/alabama-thca
- HempData. “Is Hemp Legal in Alabama? 2026 Laws + H.R. 5371” (state 0.3% context; total-THC methodology). 2026. https://hempdata.io/states/alabama
- AtlRx. “Is Delta 8 Legal in Alabama? State Law Guide 2026” (synthesized-cannabinoid prohibition; retail constraints). May 2026. https://www.atlrx.com/blogs/delta-8/is-delta-8-legal-in-alabama/
- HempHop. “Is THCa Legal in Alabama? 2026 Law & HB 445 Explained” (phased rollout; ongoing constitutional litigation; enforcement status). 2026. https://hemphop.co/blogs/news/is-thca-legal-in-alabama-thca-alabama
